- Home
- / Magellan Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Financial statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 7.3B | 7.2B | 4.6B |
| Revenue growth, % | -2.1% | -36.1% | |
| Cost of goods sold | 6.0B | 5.8B | 3.6B |
| Gross profit | 1.3B | 1.3B | 999.0M |
| Gross profit margin, % | 17.3% | 18.4% | 21.8% |
| Operating expense total | 1.2B | 1.2B | 978.6M |
| Depreciation and amortization | 132.7M | 131.5M | 98.4M |
| Interest income | 14.1M | 19.2M | 4.1M |
| Interest expense | 35.4M | 36.2M | 30.9M |
| Pre tax profit | 43.2M | 80.8M | (40.5M) |
| Income tax expense | 19.0M | 24.9M | (44.5M) |
| Net Income | 24.2M | 55.9M | 382.3M |
| EPS | 1.0 | 2.3 | 15.0 |